Detalhe da pesquisa
1.
Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment-naïve chronic hepatitis B patients.
J Viral Hepat
; 26 Suppl 1: 59-68, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31380588
2.
Histological responses of peginterferon alpha add-on therapy in patients with chronic hepatitis B with advanced liver fibrosis after long-term nucleos(t)ide analog treatment.
J Viral Hepat
; 26 Suppl 1: 50-58, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31380590
3.
Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment.
Antimicrob Agents Chemother
; 59(7): 4121-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25941216
4.
The efficacy and safety of adding on or switching to peginterferon α-2b in HBeAg-positive chronic hepatitis B patients with long-term entecavir treatment: a multicentre randomised controlled trial.
Aliment Pharmacol Ther
; 56(9): 1394-1407, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128636